ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : gene expression analysis
Scheme : Project Grants
Australian State/Territory : NSW
Clear All
Filter by Field of Research
Haematology (3)
Epigenetics (incl. Genome Methylation and Epigenomics) (2)
Haematological Tumours (2)
Medical Virology (2)
Medical and Health Sciences not elsewhere classified (2)
Central Nervous System (1)
Chemotherapy (1)
Developmental Genetics (incl. Sex Determination) (1)
Gene Expression (incl. Microarray and other genome-wide approaches) (1)
Genome Structure and Regulation (1)
Nanomedicine (1)
Structural Biology (incl. Macromolecular Modelling) (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (18)
Filter by Status
Closed (18)
Filter by Scheme
Project Grants (18)
Filter by Country
Australia (18)
Filter by Australian State/Territory
NSW (18)
ACT (1)
QLD (1)
  • Researchers (0)
  • Funded Activities (18)
  • Organisations (16)
  • Funded Activity

    Gene Expression Biomarkers Predict Severe Asthma Inflammatory Phenotype, Activation Mechanisms And Treatment Response

    Funder
    National Health and Medical Research Council
    Funding Amount
    $465,627.00
    Summary
    Asthma is now recognised to be made up of several disease variants or phenotypes, which are likely to have different underlying causes and mechanisms. We lack understanding of how to identify phenotypes of asthma and how they work, and this is delaying research that will lead to improvements in treatments and patient care. This is particularly important in people with severe disease. This grant will establish a gene test to identify asthma phenotype, and further understand mechanisms and treatme .... Asthma is now recognised to be made up of several disease variants or phenotypes, which are likely to have different underlying causes and mechanisms. We lack understanding of how to identify phenotypes of asthma and how they work, and this is delaying research that will lead to improvements in treatments and patient care. This is particularly important in people with severe disease. This grant will establish a gene test to identify asthma phenotype, and further understand mechanisms and treatment responses.
    Read more Read less
    More information
    Funded Activity

    Mechanistic And Functional Analysis Of The Id4 Proto-oncogene In Breast And Ovarian Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $693,983.00
    Summary
    Cancer arises through damage to normal regulatory processes in cells. Understanding these damaged processes is essential to implement personalized medicine. This proposal explores the role of the proto-oncogene ID4 in the closely related cancers triple negative breast cancer and serous ovarian cancer. This research may lead to the development of new therapeutic strategies or the refinement of existing strategies for these poor prognosis cancers.
    More information
    Funded Activity

    Protracted Bacterial Bronchitis: Long Term Outcomes, Systemic And Airway Predictors Of Recurrence

    Funder
    National Health and Medical Research Council
    Funding Amount
    $804,405.00
    Summary
    Our study will determine the long term clinical outcomes of children with protracted bacterial bronchitis (PBB), a common cause of chronic cough in children. We will also conduct novel experiments that were pioneered in Australia to evaluate recurrent PBB.
    More information
    Funded Activity

    Four Dimensional Epigenome Remodelling: Implications For Endocrine Resistance In Breast Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $828,560.00
    Summary
    Patients with estrogen receptor positive breast cancer receive endocrine therapy, however half fail to respond and relapse. Endocrine resistant breast cancer currently represents the most significant challenge to breast cancer treatment. We suggest that three-dimensional epigenetic remodelling is an underlying mechanism that determines endocrine sensitivity that we will exploit as a novel therapeutic strategy to effectively treat patents with recurrent disease.
    More information
    Funded Activity

    Glucocorticoid Resistance In Paediatric Acute Lymphoblastic Leukaemia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $394,721.00
    Summary
    Glucocorticoids are among the most effective drugs used in the treatment of many haematological malignancies, including leukaemia, lymphoma and multiple myeloma. However, the development of tumour cell resistance to these drugs remains a significant problem, and clinically relevant mechanisms of glucocorticoid resistance remain poorly understood. This project aims to define mechanisms of resistance to glucocorticoids and develop new drugs to reverse resistance.
    More information
    Funded Activity

    Solving Delivery Of Gene Therapy For Control Of Human Immunodeficiency Virus Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $765,439.00
    Summary
    Antiretroviral therapy free control of Human Immunodeficiency Virus (HIV) infection requires control of the viral reservoir. We have a unique approach, aimed at enforcing HIV latency by targeting highly conserved regions in the viral promoter. These constructs completely silence viral transcription for long periods of time. We intend to develop & assess vectors that are specifically targeted to the reservoir and which can enforce viral latency despite immune activation or viral variation.
    More information
    Funded Activity

    The Use Of Gene-Silencing Nanodrugs To Inhibit Lung Cancer Growth

    Funder
    National Health and Medical Research Council
    Funding Amount
    $452,950.00
    Summary
    Lung cancer accounts for the most cancer deaths worldwide. This research proposal will use state-of-the-art nanomedicines designed to penetrate lung tumours and suppress a gene which drives cancer growth and resistance to chemotherapy drugs. Our results could underpin new approaches that revolutionise more effective and less toxic treatments for a highly lethal malignancy.
    More information
    Funded Activity

    Structural And Functional Analysis Of A Cancer-linked Co-regulator Complex

    Funder
    National Health and Medical Research Council
    Funding Amount
    $729,571.00
    Summary
    We seek to understand the mechanisms by which genes are switched on and off throughout our lifetime. A number of multi-component protein machines are involved in this process but their make-up and mechanism of action is not understood. We will investigate the structure and function of one of these machines that has been strongly linked to cancer.
    More information
    Funded Activity

    Epistatic Genetic Effects On Neuroanatomical Subtypes Of Schizophrenia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $410,141.00
    Summary
    Schizophrenia represents a number of clinically distinct syndromes, with a complex mode of inheritance. The delineation of biologically valid subtypes of schizophrenia is necessary to advance our understanding of the genetic basis of these syndromes. This project uses pattern classification techniques to determine subtypes of schizophrenia on the basis of structural brain abnormality across multiple regions, and will examine genetic interactions and differential gene expression associated with t .... Schizophrenia represents a number of clinically distinct syndromes, with a complex mode of inheritance. The delineation of biologically valid subtypes of schizophrenia is necessary to advance our understanding of the genetic basis of these syndromes. This project uses pattern classification techniques to determine subtypes of schizophrenia on the basis of structural brain abnormality across multiple regions, and will examine genetic interactions and differential gene expression associated with these biologically-derived subtypes.
    Read more Read less
    More information
    Funded Activity

    HIV-1 Transcriptional Gene Silencing By Promoter Targeted Si/shRNAs: Uncovering Mechanisms, Optimising Delivery Systems, Assessing In Vivo Efficacy.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $641,789.00
    Summary
    Current therapy for HIV is effective but must be taken for life. If therapy is stopped the virus comes back immediately from reservoirs not affected by current drugs. These fluctuating levels of virus are associated with increased illness and death. We are exploring a method of inducing prolonged viral latency using short double stranded RNA molecules. We propose to understand the mechanism of action of these possible therapeutics and to develop these constructs towards use in clinical trials.
    More information

    Showing 1-10 of 18 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback